stocktrader.studio
  • Our data
  • Exchanges
  • Pricing
  • Learn
  • News
Go to the app
AllEarnings

CVS Health Puts Pharmacy Muscle to Work as Aetna Rebuilds Margins

Feb 10, 2026
CVS Health CorpCVS Health Corp

Bristol Myers pivots from Revlimid drag to Eliquis-fuelled transition year

Feb 5, 2026
Bristol-Myers Squibb CoBristol-Myers Squibb Co

Amazon’s AI Capex Super‑Cycle Meets a Faster, Cheaper Retail Engine

Feb 5, 2026
Amazon.com IncAmazon.com Inc

Qualcomm’s Record Quarter Meets an Old Nemesis: the Memory Cycle

Feb 4, 2026
Qualcomm IncQualcomm Inc

Uber bets its balance sheet on the AV “multitrillion‑dollar” future

Feb 4, 2026
Uber Technologies IncUber Technologies Inc

Boston Scientific banks on breadth as EP boom normalises

Feb 4, 2026
Boston Scientific CorpBoston Scientific Corp

Alphabet’s $185bn AI Bet Recasts the Balance Sheet for the Gemini Era

Feb 4, 2026
Alphabet IncAlphabet Inc

AMD Targets a 60% Data Center Growth Trajectory as AI Supercycle Takes Hold

Feb 3, 2026
Advanced Micro Devices IncAdvanced Micro Devices Inc

Amgen bets its decade on cardiometabolic moonshot as legacy blockbusters erode

Feb 3, 2026
Amgen IncAmgen Inc

PayPal’s Checkout Squeeze Forces Reset as Board Brings in New CEO

Feb 3, 2026
PayPal Holdings IncPayPal Holdings Inc

PepsiCo banks on affordability and aisle expansion as U.S. consumer stays “choiceful”

Feb 3, 2026
PepsiCo IncPepsiCo Inc

Pfizer banks on ultra‑long‑acting GLP‑1 as post‑COVID portfolio takes shape

Feb 3, 2026
Pfizer IncPfizer Inc
Previous Next
stocktrader.studio

© Copyright 2026 All Rights Reserved by
Trading Studio LTD.

  • T&Cs
  • Privacy Policy
  • Contact

stocktrader.studio does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Information is provided 'as-is' and solely for informational purposes and is not advice. stocktrader.studio does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.